US research roundup: Affiliated Managers Group, Goldman Sachs, Vaxcyte
SPY•Analysts revised ratings and price targets on several U.S.-listed companies on Tuesday. Jefferies raised Affiliated Managers Group’s target to $456 from $441 and cut Goldman Sachs’ to $1,124 from $1,299; Needham raised Vaxcyte’s target to $122 from $110.
1. Selected target changes
The roundup also included JP Morgan raising Regeneron’s price target to $950 from $900 and Jefferies raising Charles Schwab’s to $131 from $126. The listed analyst actions covered companies across multiple industries.
